MediPharm Labs Corp.
Rank 17
About
MediPharm is aligned with a strategy that focuses on cannabis-derived products through extraction, isolation, and purification. Ventures in Canada and Australia will provide both markets with cannabis oil that meets cGMP and ISO standards. Founded in 2015, the company is involved with several global research and development projects.
$4.1163
USD
2.46%
Market cap
$534,340,079
Total volume
$2,503,777
Shares outstanding
129,810,961
Rank 17
About
MediPharm is aligned with a strategy that focuses on cannabis-derived products through extraction, isolation, and purification. Ventures in Canada and Australia will provide both markets with cannabis oil that meets cGMP and ISO standards. Founded in 2015, the company is involved with several global research and development projects.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
LABS |
$1,478,218
|
59.04% |
$4.1163
|
| MEDIF |
Total volume
$257,485
|
10.28% |
Stock price
$0.9200
|
Chart